Data from three terminally ill cardiogenic shock patients showcase potential of procizumab to safely reverse shock within 48 hours and p ...

The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.

Berlin: Bayer has received approval from the U.S. Food and Drug Administration (FDA) for finerenone (Kerendia), a ...

Women diagnosed with premenstrual symptoms have a slightly increased risk of developing cardiovascular disease later in life.

Researchers found an 11% higher risk for cardiovascular disease in women diagnosed with severe symptoms, not just mild or ...

Women diagnosed with premenstrual symptoms have a slightly increased risk of developing cardiovascular disease later in life.

Women diagnosed with premenstrual symptoms have a slightly increased risk of developing cardiovascular disease later in life.

Coconut water, a natural electrolyte beverage, may help lower blood pressure. However, there's not much evidence to support ...

ARO-C3 is an investigational RNA interference therapeutic designed to reduce liver production of complement component 3 as a potential therapy for various complement-mediated diseases.